- Tips for Spending Holiday Time With Family Members Who Live with Dementia
- Tainted Cucumbers Now Linked to 100 Salmonella Cases in 23 States
- Check Your Pantry, Lay’s Classic Potato Chips Recalled Due to Milk Allergy Risk
- Norovirus Sickens Hundreds on Three Cruise Ships: CDC
- Not Just Blabber: What Baby’s First Vocalizations and Coos Can Tell Us
- What’s the Link Between Memory Problems and Sexism?
- Supreme Court to Decide on South Carolina’s Bid to Cut Funding for Planned Parenthood
- Antibiotics Do Not Increase Risks for Cognitive Decline, Dementia in Older Adults, New Data Says
- A New Way to Treat Sjögren’s Disease? Researchers Are Hopeful
- Some Abortion Pill Users Surprised By Pain, Study Says
Many Dentists Still Giving Patients Addictive Opioid Painkillers
Though most U.S. dentists say non-opioid painkillers effectively manage dental pain, nearly half still prescribe potentially addictive opioid painkillers, a new survey reveals.
In all, 84% of the 269 respondents said NSAID-acetaminophen combos are as effective as opioids or even more so, but 43% also said they regularly prescribe opioid medications.
The findings were published Oct. 21 in the Journal of the American Dental Association.
“These results suggest that dentists are familiar with the evidence about the effectiveness of NSAID-acetaminophen medications, but their self-reported prescribing patterns demonstrate a disconnect,” said first author Matthew Heron, who conducted the study as an undergraduate at Georgetown University’s School of Nursing and Health Studies in Washington, D.C. He spoke in a Georgetown news release.
Previous studies have found that dentists represent 8.6% of opioid prescribers in the United States, and are the biggest prescribers of opioids to patients 18 and younger.
“We know that the first exposure to opioids for many people occurs in their teens and early 20s following common dental procedures like third molar extractions,” said study co-author Nkechi Nwokorie, who also conducted the work as a Georgetown undergrad. “This is a particularly vulnerable population for misuse.”
Dr. Adriane Fugh-Berman is director of PharmedOut, a Georgetown project that was involved in the study.
“This underscores the need for more education about the harms of opioids and the need for national guidelines to align clinical practice with current evidence,” she said. Fugh-Berman is also a professor in the departments of pharmacology, physiology and family medicine at Georgetown University Medical Center.
More information
The U.S. National Institute on Drug Abuse has more about prescription opioids.
SOURCE: Georgetown University Medical Center, news release, Oct. 21, 2021
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.